Cargando…
Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings
The hemostatic properties of recombinant activated factor VII (rFVIIa) are established in patients with inherited or acquired hemophilia with inhibitors and in patients with congenital factor VII deficiencies. Emerging clinical evidence suggests that there may be a wider role for rFVIIa in the manag...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226121/ https://www.ncbi.nlm.nih.gov/pubmed/16221317 http://dx.doi.org/10.1186/cc3783 |